Nasdaq:US$16.36 (-0.09) | HKEX:HK$26.00 (-0.10) | AIM:£2.62 (-0.09)
Search
EN
简
繁
About Us
Overview
Corporate Information
Board of Directors
Leadership
Sustainability
Contact Us
What We Do
Overview
Research and Development
Commercialization in China
Other Ventures
Key Corporate Partnerships
Pipeline & Products
Overview
Our Products
Our Pipeline
Expanded Access
News & Publications
News & Press Releases
Scientific Publications
Mailing List Sign-up
Shareholder Information
Overview
Announcements
Events, Presentations & Circulars
Share Price & Chart
Major Shareholders
Financial Reports & Filings
Analyst Coverage
Listing FAQs for Shareholders
Information for Shareholders
Corporate Governance
AIM Rule 26
Dissemination of Corporate Communications
Modern Slavery and Human Trafficking Statement
Careers
About Us
Overview
Corporate Information
Board of Directors
Leadership
Sustainability
Contact Us
What We Do
Overview
Research and Development
Commercialization in China
Other Ventures
Key Corporate Partnerships
Pipeline & Products
Overview
Our Products
Our Pipeline
Expanded Access
News & Publications
News & Press Releases
Scientific Publications
Mailing List Sign-up
Shareholder Information
Overview
Announcements
Events, Presentations & Circulars
Share Price & Chart
Major Shareholders
Financial Reports & Filings
Analyst Coverage
Listing FAQs for Shareholders
Information for Shareholders
Corporate Governance
AIM Rule 26
Dissemination of Corporate Communications
Modern Slavery and Human Trafficking Statement
Careers
Search Result
Chi-Med
Search Result
| 中期报告
Previous Article
|
Next Article
中期报告
| 10 Aug 2018
2018年中期报告
Contents
Corporate Information
Contents
1
Highlights
2
Chairman’s Statement
7
Financial Review
8
Operations Review
10
Condensed Consolidated Balance Sheets
29
Condensed Consolidated Statements of Operations
30
Condensed Consolidated Statements of Comprehensive (Loss)/Income
31
Condensed Consolidated Statements of Changes in Shareholders' Equity
32
Condensed Consolidated Statements of Cash Flows
33
Notes to Unaudited Condensed Consolidated Financial Statements
34
Information For Shareholders
68